CONVENTUS BIOMEDICAL SOLUTIONS, INC. is a privately-held, expert-level consulting firm specializing in regulatory strategies and requirements for biopharmaceutical products in early development stages through Phase 3. The Conventus team maintains offices in the Sorrento Valley area of San Diego and is led by Mr. Steven Kradjian, a Senior Regulatory Affairs professional who has led 27 successful IND filings at Conventus. Conventus’ recent experience includes two biologics INDs in cardiovascular disease indications, and deep experience from planning the regulatory approach to expedite prudent development of biological and pharmaceutical products, to planning, writing, and filing these INDs with no clinical holds. In addition, Conventus has deep and recent experience working with FDA to address and resolve CMC issues for biological products in lyophilized dosage forms, mid-development formulation changes, potency method development for rDNA proteins, and negotiating carcinogenicity, pharmacology and toxicology requirements with FDA. SERVICES OFFERED • Global Regulatory Management • Quality Assurance/Change Control • CMC Biologics and Small Molecules • Pharmacology (PK/PD)/Toxicology Planning and Oversight • Clinical Operations • Regulatory Strategies for Biosimilars • Regulatory Strategies for Combination Products
View Top Employees from Conventus Biomedical Solutions, Inc.Website | http://www.conventusbiomed.com |
Revenue | $2 million |
Employees | 9 (9 on RocketReach) |
Founded | 2005 |
Address | 5414 Oberlin Dr. Ste. # 130, San Diego, California 92121, US |
Phone | (858) 401-2111 |
Technologies | |
Industry | Biotechnology, Drug Stores & Pharmacies, Regulatory Affairs Consulting, Retail, CMC Biologics and Small Molecules, Quality Assurance/Change Control, Pharmacology (PK/PD)/Toxicology Planning and Oversight, Clinical Operations, Management Consulting, Regulatory Strategies for Biosimilars and Combination Products |
Web Rank | 25 Million |
Keywords | Conventus Biomedical Solutions |
Competitors | Biomedical Consulting International, Inc., Inpernum Pharma Solutions, Pharmaceutical Development Group, Salamandra, LLC, Universal Regulatory, Inc |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Conventus Biomedical Solutions, Inc. employee's phone or email?
The Conventus Biomedical Solutions, Inc. annual revenue was $2 million in 2024.
Steven Kradjian is the President and Principal Regulatory Consultant of Conventus Biomedical Solutions, Inc..
9 people are employed at Conventus Biomedical Solutions, Inc..
Conventus Biomedical Solutions, Inc. is based in San Diego, California.
The NAICS codes for Conventus Biomedical Solutions, Inc. are [3254, 325, 32541, 32].
The SIC codes for Conventus Biomedical Solutions, Inc. are [28, 283].